-
1
SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
Veröffentlicht 2016kostenfrei
kostenfrei
kostenfrei
Elektronisch E-Book -
2
Interlaboratory proficiency processing scheme in CSF aliquoting implementation and assessment based on biomarkers of Alzheimer's disease
Veröffentlicht 2018kostenfrei
kostenfrei
kostenfrei
Elektronisch E-Book -
3